Published in J Cardiovasc Transl Res on March 31, 2010
Acute exercise stress activates Nrf2/ARE signaling and promotes antioxidant mechanisms in the myocardium. Free Radic Biol Med (2011) 1.39
Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome. Cardiorenal Med (2012) 0.98
Mitochondria play a central role in nonischemic cardiomyocyte necrosis: common to acute and chronic stressor states. Pflugers Arch (2012) 0.93
Angiotensin II and oxidative stress in the failing heart. Antioxid Redox Signal (2012) 0.88
β₂-Adrenoceptors, NADPH oxidase, ROS and p38 MAPK: another 'radical' road to heart failure? Br J Pharmacol (2011) 0.85
QSYQ Attenuates Oxidative Stress and Apoptosis Induced Heart Remodeling Rats through Different Subtypes of NADPH-Oxidase. Evid Based Complement Alternat Med (2013) 0.80
Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies. Heart Fail Rev (2012) 0.80
ALDH2 attenuates Dox-induced cardiotoxicity by inhibiting cardiac apoptosis and oxidative stress. Int J Clin Exp Med (2015) 0.78
Sanguinarine inhibits angiotensin II-induced apoptosis in H9c2 cardiac cells via restoring reactive oxygen species-mediated decreases in the mitochondrial membrane potential. Mol Med Rep (2015) 0.75
Cytoprotective effect of rhamnetin on miconazole-induced H9c2 cell damage. Nutr Res Pract (2015) 0.75
The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev (2007) 21.13
NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol (2004) 12.93
Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol (2006) 10.71
Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest (2003) 6.30
Oxidant signals and oxidative stress. Curr Opin Cell Biol (2003) 5.67
Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest (2005) 5.53
NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res (2005) 4.66
A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest (2003) 3.96
NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J (2007) 3.88
Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol (2003) 3.73
Nox proteins in signal transduction. Free Radic Biol Med (2009) 3.47
Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J (2008) 3.04
Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res (2009) 2.83
Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res (1999) 2.69
Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res (2010) 2.65
Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation (2002) 2.57
Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res (2003) 2.50
Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation (2002) 2.50
A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell (2008) 2.47
Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res (2000) 2.45
Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun (2005) 2.34
Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med (2005) 2.29
Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension (2002) 2.20
Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med (2000) 2.13
Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res (2008) 1.96
Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol (2003) 1.91
Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J (2006) 1.90
Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid Redox Signal (2009) 1.80
Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ Res (2007) 1.77
The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activation. Mol Biol Cell (2006) 1.76
The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle. Cardiovasc Res (2005) 1.72
Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system. Am J Hypertens (2004) 1.67
NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther (2008) 1.58
Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Physiol Genomics (2006) 1.57
Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation (1998) 1.57
Oxygen free radicals and congestive heart failure. Br Heart J (1991) 1.55
Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation (1997) 1.50
Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol (1996) 1.50
Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am J Physiol Cell Physiol (2002) 1.49
Oxidative stress causes heart failure with impaired mitochondrial respiration. J Biol Chem (2006) 1.48
Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxid Redox Signal (2005) 1.45
NADPH oxidase inhibitors: new antihypertensive agents? J Cardiovasc Pharmacol (2007) 1.44
Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail (2005) 1.38
The reactive adventitia: fibroblast oxidase in vascular function. Arterioscler Thromb Vasc Biol (2002) 1.31
Pressure overload-induced myocardial hypertrophy in mice does not require gp91phox. Circulation (2004) 1.29
Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis (2009) 1.27
Reactive oxygen species and matrix remodeling in diabetic kidney. J Am Soc Nephrol (2003) 1.24
Urokinase plasminogen activator stimulates vascular smooth muscle cell proliferation via redox-dependent pathways. Arterioscler Thromb Vasc Biol (2006) 1.20
Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Fail (2009) 1.17
NADPH oxidase isoform selective regulation of endothelial cell proliferation and survival. Naunyn Schmiedebergs Arch Pharmacol (2009) 1.15
NADPH oxidase signaling and cardiac myocyte function. J Mol Cell Cardiol (2009) 1.12
Elucidation of thioredoxin target protein networks in mouse. Mol Cell Proteomics (2009) 1.11
NADPH oxidase is involved in angiotensin II-induced apoptosis in H9C2 cardiac muscle cells: effects of apocynin. Free Radic Biol Med (2005) 1.09
The role of nitric oxide in myocardial repair and remodeling. Antioxid Redox Signal (2009) 1.05
Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage. Am J Physiol Heart Circ Physiol (2003) 1.02
The role of redox modulation of class II histone deacetylases in mediating pathological cardiac hypertrophy. J Mol Med (Berl) (2009) 1.01
Regulation of xanthine oxidoreductase protein expression by hydrogen peroxide and calcium. Arterioscler Thromb Vasc Biol (2005) 0.94
The role of urate and xanthine oxidase inhibitors in cardiovascular disease. Cardiovasc Ther (2008) 0.92
Mitochondrial oxidative stress and heart failure. Intern Med (2006) 0.91
Greater susceptibility of failing cardiac myocytes to oxygen free radical-mediated injury. Cardiovasc Res (2001) 0.90
NADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblasts. Cardiovasc Res (2007) 0.86
Targeting histone deacetylases for heart failure. Expert Opin Ther Targets (2009) 0.86
Antioxidative enzymes in human hearts with idiopathic dilated cardiomyopathy. J Mol Cell Cardiol (2000) 0.83
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res (2007) 8.44
Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res (2007) 5.23
Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A (2005) 3.55
Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res (2009) 3.53
Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem (2006) 3.40
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A (2002) 3.18
Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell (2007) 2.96
NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci U S A (2010) 2.95
Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ Res (2004) 2.82
Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res (2010) 2.65
Deacetylation of FoxO by Sirt1 Plays an Essential Role in Mediating Starvation-Induced Autophagy in Cardiac Myocytes. Circ Res (2010) 2.57
Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy. Circulation (2006) 2.50
A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell (2008) 2.47
Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ Res (2002) 2.32
Inhibition of glycogen synthase kinase 3beta during heart failure is protective. Circ Res (2007) 2.22
Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. J Clin Invest (2003) 2.20
Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation (2010) 2.19
Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest (2003) 2.19
Differential roles of GSK-3β during myocardial ischemia and ischemia/reperfusion. Circ Res (2011) 2.10
Repetitive ischemia by coronary stenosis induces a novel window of ischemic preconditioning. Circulation (2008) 2.09
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ Res (2004) 2.08
Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat Med (2013) 1.93
Endogenous muscle atrophy F-box mediates pressure overload-induced cardiac hypertrophy through regulation of nuclear factor-kappaB. Circ Res (2011) 1.79
Oxidative stress stimulates autophagic flux during ischemia/reperfusion. Antioxid Redox Signal (2011) 1.76
Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res (2009) 1.74
Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction. Circ Res (2007) 1.66
Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc Natl Acad Sci U S A (2003) 1.64
Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes. Cardiovasc Res (2008) 1.59
Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res (2014) 1.59
Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload. Proc Natl Acad Sci U S A (2008) 1.58
Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation (2012) 1.56
Lats2 is a negative regulator of myocyte size in the heart. Circ Res (2008) 1.53
Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. J Biol Chem (2003) 1.47
Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion. Autophagy (2008) 1.46
Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice. J Clin Invest (2005) 1.45
Regulation of myocardial growth and death by NADPH oxidase. J Mol Cell Cardiol (2011) 1.44
Novel methods for measuring cardiac autophagy in vivo. Methods Enzymol (2009) 1.43
Caspase-3 mediated cleavage of MEKK1 promotes p53 transcriptional activity. J Mol Cell Cardiol (2006) 1.43
Enhanced autophagy ameliorates cardiac proteinopathy. J Clin Invest (2013) 1.41
SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2008) 1.39
AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs. J Biol Chem (2002) 1.37
Quantitative analysis of redox-sensitive proteome with DIGE and ICAT. J Proteome Res (2008) 1.37
Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation. Sci Transl Med (2010) 1.35
Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy. Circ Res (2004) 1.35
A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis. Proc Natl Acad Sci U S A (2005) 1.34
Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy. Circ Res (2012) 1.30
An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy. Circ Res (2006) 1.30
Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice. J Clin Invest (2010) 1.29
Is autophagy in response to ischemia and reperfusion protective or detrimental for the heart? Pediatr Cardiol (2010) 1.29
Negative regulators of cardiac hypertrophy. Cardiovasc Res (2004) 1.29
AMPK mediates autophagy during myocardial ischemia in vivo. Autophagy (2007) 1.28
Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7. Circ Res (2010) 1.26
Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation. Circ Res (2003) 1.25
The role of autophagy in mediating cell survival and death during ischemia and reperfusion in the heart. Antioxid Redox Signal (2007) 1.25
Redox regulatory mechanism of transnitrosylation by thioredoxin. Mol Cell Proteomics (2010) 1.23
Distinct roles of glycogen synthase kinase (GSK)-3alpha and GSK-3beta in mediating cardiomyocyte differentiation in murine bone marrow-derived mesenchymal stem cells. J Biol Chem (2009) 1.22
Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases. J Biol Chem (2007) 1.22
Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury. J Biol Chem (2012) 1.18
Myocardial injection with GSK-3β-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction. Circ Res (2011) 1.17
Dietary restriction: standing up for sirtuins. Science (2010) 1.17
Inhibition of p38 alpha MAPK rescues cardiomyopathy induced by overexpressed beta 2-adrenergic receptor, but not beta 1-adrenergic receptor. J Clin Invest (2007) 1.17
Adenylyl cyclase type 5 protein expression during cardiac development and stress. Am J Physiol Heart Circ Physiol (2009) 1.16
GDF15, a cardioprotective TGF-beta superfamily protein. Circ Res (2006) 1.16
Redox modification of cell signaling in the cardiovascular system. J Mol Cell Cardiol (2011) 1.15
Is treating cardiac hypertrophy salutary or detrimental: the two faces of Janus. Am J Physiol Heart Circ Physiol (2003) 1.15
Rapid upregulation of CTGF in cardiac myocytes by hypertrophic stimuli: implication for cardiac fibrosis and hypertrophy. J Mol Cell Cardiol (2004) 1.14
Thioredoxin and ventricular remodeling. J Mol Cell Cardiol (2006) 1.14
Sirt1 protects the heart from aging and stress. Biol Chem (2008) 1.11
Elucidation of thioredoxin target protein networks in mouse. Mol Cell Proteomics (2009) 1.11
Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. Am J Pathol (2010) 1.11
Histone H2A.z is essential for cardiac myocyte hypertrophy but opposed by silent information regulator 2alpha. J Biol Chem (2006) 1.11
H11 kinase is a novel mediator of myocardial hypertrophy in vivo. Circ Res (2002) 1.09
Autophagy in ischemic preconditioning and hibernating myocardium. Autophagy (2009) 1.09
Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart. PLoS One (2013) 1.09
Persistent stunning induces myocardial hibernation and protection: flow/function and metabolic mechanisms. Circ Res (2003) 1.09
PPARα-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway. Cell Metab (2011) 1.08
Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation. Am J Pathol (2009) 1.07
Thioredoxin1 as a negative regulator of cardiac hypertrophy. Antioxid Redox Signal (2007) 1.07
Thioredoxin1 upregulates mitochondrial proteins related to oxidative phosphorylation and TCA cycle in the heart. Antioxid Redox Signal (2006) 1.04
The NADPH oxidase Nox4 and aging in the heart. Aging (Albany NY) (2010) 1.04
The role of redox modulation of class II histone deacetylases in mediating pathological cardiac hypertrophy. J Mol Med (Berl) (2009) 1.01
Pathophysiological roles of NADPH oxidase/nox family proteins in the vascular system. -Review and perspective-. Circ J (2011) 1.00
Comparative analysis of mRNA isoform expression in cardiac hypertrophy and development reveals multiple post-transcriptional regulatory modules. PLoS One (2011) 0.99
Translocation of caveolin regulates stretch-induced ERK activity in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2004) 0.99
H11 has dose-dependent and dual hypertrophic and proapoptotic functions in cardiac myocytes. Biochem J (2005) 0.99
Distinction of thioredoxin transnitrosylation and denitrosylation target proteins by the ICAT quantitative approach. J Proteomics (2011) 0.98
Thioredoxin 1-mediated post-translational modifications: reduction, transnitrosylation, denitrosylation, and related proteomics methodologies. Antioxid Redox Signal (2011) 0.97
Autophagy: a novel protective mechanism in chronic ischemia. Cell Cycle (2006) 0.96
C2238 atrial natriuretic peptide molecular variant is associated with endothelial damage and dysfunction through natriuretic peptide receptor C signaling. Circ Res (2013) 0.95
Thioredoxin 1 is essential for sodium sulfide-mediated cardioprotection in the setting of heart failure. Arterioscler Thromb Vasc Biol (2013) 0.95
Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor. J Biol Chem (2003) 0.95
Regulation of cell survival and death by pyridine nucleotides. Circ Res (2012) 0.95
Redox regulation of growth and death in cardiac myocytes. Antioxid Redox Signal (2006) 0.92
Overview of pyridine nucleotides review series. Circ Res (2012) 0.92
Cytochrome c oxidase III as a mechanism for apoptosis in heart failure following myocardial infarction. Am J Physiol Cell Physiol (2009) 0.92